3 studies found for:    6628
Show Display Options
Rank Status Study
1 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer;   Triple-negative Breast Cancer
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Biological: bevacizumab;   Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
2 Recruiting Attaining and Maintaining Wellness in Obsessive-compulsive Disorder
Condition: Obsessive Compulsive Disorder
Interventions: Behavioral: Monthly Booster Sessions of EX/RP;   Procedure: Visits with MD and independent evaluators
3 Not yet recruiting Comparison of Stress Reduction Techniques
Condition: Stress
Interventions: Behavioral: Program 2;   Behavioral: Program 1

Indicates status has not been verified in more than two years